Since 1997, Merck has promoted Propecia as an efficacious treatment for androgenic alopecia, better known as male pattern hair loss. Over one million men have used the medication since its launch, under the assumption that Propecia (generic name: finasteride) carried minimal risks of adverse side... Read More

In August 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) decided to consolidate all products liability claims brought in federal courts nationwide involving incretin mimetics – a controversial class of diabetes drugs that have been linked to pancreatitis and cancer of the pancreas. The... Read More

A recent study in the British Medical Journal reported that when pregnant women take antidepressants close to their delivery date, they are at an increased risk for postpartum hemorrhaging. This study is one of many that reports that antidepressants can have very harmful effects on... Read More

The Orange County Register reports at least 71 deaths associated with da Vinci robot surgery since 2000, according to a recent study. The number of “injury” or “death” events in FDA records reached 105 in August 2013, more than triple the rate of any prior month, according to... Read More

Bloomberg reports that several pelvic mesh manufacturers including C.R. Bard, Boston Scientific and Endo Health Solutions may be entering behind-the-scenes talks with plaintiffs in an effort to negotiate transvaginal mesh settlements. Insiders who are familiar with the ongoing vaginal mesh litigation told the news source... Read More

A federal judge overseeing the multidistrict litigation against the Johnson & Johnson-owned subsidiary Ethicon over their vaginal mesh implants has ordered first trial to begin in August 2014. There are more than 10,000 Ethicon Prolift mesh lawsuits currently pending in the federal court system. Vaginal... Read More

Recent research conducted by a team at Stanford’s School of Medicine found that exposure to large quantities of Medtronic Infuse recombinant bone morphogenetic protein-2 (rhBMP-2) was linked with an increased rate of cancer. The results of the study, which highlight the Medtronic Infuse cancer risk,... Read More

In Actos lawsuit news, Takeda Pharmaceuticals continues to defend claims that it failed to warn consumers that its flagship type 2 diabetes medication causes a disproportionately high risk for developing bladder cancer. A bundled complaint filed by fourteen plaintiffs recently joined the Actos products liability... Read More